MRNS — Marinus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Marinus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	91.7	140	123	241	150
Net Total Accounts Receivable
Net Total Receivables	—	1.65	3.19	6.35	3.8
Total Inventory
Prepaid Expenses
Total Current Assets	94.1	146	132	252	165
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.76	3.94	4.2	5.54	4.84
Other Long Term Assets
Total Assets	98.8	150	137	260	171
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8.03	10.7	40.6	25	40.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.1	13.3	83.4	144	154
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	87.8	137	53.5	116	16.8
Total Liabilities & Shareholders' Equity	98.8	150	137	260	171
Total Common Shares Outstanding
Total Preferred Shares Outstanding